Topic: HPV

The COVID-19 pandemic prompted renewed emphasis on monitoring vaccine confidence. This study extends vaccine confidence surveillance to geographies where such research is limited. 

This study aims to expand the scope of HCPs’ vaccine confidence oversight into European regions where limited research has been conducted thus far.

This study aimed to identify drivers of HPV vaccine hesitancy and effective public health interventions to increase HPV vaccination rates in two U.S. states (New York and Florida). The findings provide insights into the impact of demographics, state policies, and vaccine confidence on HPV vaccination.

This study assesses the effectiveness of a vaccine chatbot in improving human papillomavirus (HPV) vaccination among female middle school students aged 12–15 years across diverse socioeconomic settings in China, where HPV vaccination is primarily paid out-of-pocket.

Mixed method study to examine adult and HCP confidence in vaccination in Eastern Europe (Balkans, Caucasus, Central Asia).

In 2018, the European Commission engaged the Vaccine Confidence Project to create the first “State of Vaccine Confidence in the EU” report. Since then, the VCP has conducted bi-annual research to map and monitor public attitudes to vaccines across the region and examine trends over time.

In this VACCELERATE webinar, Heidi Larson will present the key findings of the State of Vaccine Confidence in the EU report, 2022.

This research aims to develop and evaluate a suite of feasible interventions based on artificial intelligence technologies checking extensions, real-time dashboards, and chatbots – that improve the ability to debunk misinformation, boost self-efficacy in the vaccination decision-making process.

This research applies communication and behavioural theories to comprehensively assess confidence in and acceptance of HPV vaccines in Japan, Korea, and China amongst people who have not received the vaccine, in order to develop effective digital communication strategies to increase uptake.

Overview ​​The global community of practice around HPV vaccination is not formalised to cut across multiple disciplines, and thought leaders from low-…

Overview Human Papillomavirus (HPV) is the fourth biggest cause of mortality amongst women in Brazil according to the Pan American Health Organisation (PAHO) but COVID-19…

A new report on the level of public confidence in vaccines among Europeans shows a strong majority believe vaccines are important, effective and safe.